Austria
Biotechnology
Pharmaceutical

Opportunity Summary

The Vaccines for Africa: Roll-out and Production in South Africa (SAVax) programme invites qualified Chambers of Commerce, Business Organisations and Consortia to submit proposals for facilitating strategic partnerships, knowledge exchange and investment linkages between European and South African pharmaceutical and biotechnology ecosystems.

Implemented by GIZ South Africa, Lesotho & eSwatini and co-financed by the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ), the programme aims to strengthen South Africa's vaccine manufacturing ecosystem through international collaboration, investment attraction and technology partnerships.

Eligibility

Eligible applicants include:

  • Chambers of Commerce
  • Business Organisations
  • Industry Associations
  • Trade Promotion Organisations
  • Investment Promotion Agencies
  • Pharmaceutical Associations
  • Business Networks
  • Consortia of business organisations.

Countries

South Africa, Germany, Netherlands, Belgium, France, Italy, Spain, Portugal, Denmark, Sweden, Finland, Austria, Ireland, Norway, Switzerland, United Kingdom.

Key Activities

  • European stakeholder engagement
  • Business matchmaking
  • Investment promotion
  • Technology transfer
  • Industry dialogue
  • Study tours
  • Partnership development
  • Policy engagement.

Closing Date

27 July 2026

Organisation

GIZ South Africa, Lesotho & eSwatini

Programme

Vaccines for Africa: Roll-out and Production in South Africa (SAVax)

Click HERE to visit the official website. 

Closing date
Industry
​Manufacturing
Professional, scientific and technical activities
Human health and social work activities
​Other service activities
Website link
https://www.giz.de/en/call-proposals-7000016307-facilitation-knowledge-exchange-partnerships-and-investment-linkages